| 5.28 Data as of May 24 |  +0.05 / +0.96%Today’s Change | 4.20 Today|||52-Week Range 8.53 | -23.03% Year-to-Date |
| Other institutional | 1.29% |
| Mutual fund holders | 0.24% |
| Individual stakeholders | -- |
| 3/31/2013 | CIBC WORLD MARKETS, INC. Bought 45.9 Thousand shares of Nymox Pharmaceutical Corp |
| 3/31/2013 | WMS PARTNERS LLC Bought 15.1 Thousand shares of Nymox Pharmaceutical Corp |
| 3/31/2013 | GOLDMAN SACHS & CO. Bought 14.6 Thousand shares of Nymox Pharmaceutical Corp |
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Susquehanna Investment Group LLC | 0.33% | 110,749 | 570,357 | -8,576 | -7.19% |
| Marathon Capital Management LLC | 0.29% | 97,700 | 503,155 | -14,000 | -12.53% |
| Crystal Fund Management AG | 0.16% | 55,000 | 283,250 | +55,000 | -- |
| WMS Partners LLC | 0.15% | 51,850 | 267,028 | +15,050 | +40.90% |
| CIBC World Markets, Inc. | 0.14% | 45,928 | 236,529 | +45,928 | -- |
| Gofen & Glossberg LLC | 0.07% | 25,000 | 128,750 | 0 | 0.00% |
| BluMont Capital Corp. | 0.05% | 18,000 | 92,700 | +80 | +0.45% |
| The California Public Employees R... | 0.05% | 15,200 | 78,280 | 0 | 0.00% |
| D. F. Dent & Co., Inc. | 0.04% | 15,000 | 77,250 | -17,000 | -53.12% |
| Goldman Sachs & Co. | 0.04% | 14,580 | 75,087 | +14,580 | -- |
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Global Opportunities Fund | 0.09% | 30,000 | 154,500 | +30,000 | -- |
| IcEight+ Fund | 0.07% | 25,000 | 128,750 | +25,000 | -- |
| BluMont Hirsch Performance Fund | 0.05% | 18,000 | 92,700 | +80 | +0.45% |
| Fidelity Nasdaq Composite Index | 0.01% | 3,188 | 16,418 | 0 | 0.00% |
| Vanguard Growth & Income Fund | 0.01% | 2,800 | 14,420 | 0 | 0.00% |
| Fidelity Nasdaq Composite Index T... | 0.00% | 1,248 | 6,427 | +78 | +6.67% |
.
